Caen, France

Cecile Enguehard

This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Cecile Enguehard

Introduction

Cecile Enguehard is a notable inventor based in Caen, France. She has made significant contributions to the field of chemistry, particularly with her innovative work on specific compounds. Her dedication to research and development has led to the creation of a unique patent that showcases her expertise.

Latest Patents

Cecile Enguehard holds a patent for 8H-thieno-[2,3-b]pyrrolizin-8-one compounds. This patent includes a compound selected from those of formula (I), wherein R₁ represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy, or optionally substituted amino. This innovation highlights her ability to explore complex chemical structures and their potential applications.

Career Highlights

Throughout her career, Cecile has demonstrated a strong commitment to advancing her field. She is currently associated with Adir Et Compagnie, where she continues to engage in research and development. Her work has not only contributed to her personal achievements but has also enhanced the reputation of her organization.

Collaborations

Cecile Enguehard has collaborated with talented individuals such as Sylvain Rault and Max Robba. These partnerships have allowed her to expand her research capabilities and foster innovation within her projects.

Conclusion

Cecile Enguehard is a remarkable inventor whose work in chemistry has led to significant advancements. Her patent for 8H-thieno-[2,3-b]pyrrolizin-8-one compounds exemplifies her innovative spirit and dedication to her field. Through her career and collaborations, she continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…